Founded by entrepreneurs disguised as scientists at the University of Kansas, Likarda is an exciting biotech company bringing to market disruptive technologies that improve healthcare outcomes and lower costs for pets and people alike. As the leading regenerative medicine company for companion animals, Likarda has discovered — and is commercializing — a new dimension for managing diabetes in dogs and cats.
Likarda utilizes a proprietary cell culture system to create three-dimensional cell clusters, or miniaturized organs, having applications in markets from drug discovery and development to cell-based transplantation and regenerative medicine. Likarda combines visionary leadership, science that is just as artistic as academic and a compelling urge to do what’s right. What results is a new dimension in healing pets and people.
But that is just the beginning. Because Likarda’s technologies span across animal and human platforms, this next generation company is already becoming a pioneer for future generations of translational medicine.
News & Media
Lisa Stehno-Bittel: Overcomplexified: How I Learned to Love My Simple Mind
KU Elevate: Innovation in Action – October 16, 2015
Likarda: 3D cell clusters are future of drug development
Animal Pharm – October 8, 2015
Metro startup company could change the way pets with diabetes live
KCTV5 – May 19, 2015
Company Wants your Pet as a Donor?
Grady Newsource – April 14, 2015
Organ Donations For Your Pet?
The Daily Beast – April 11, 2015
30 Under 30: Karthik Ramachandran makes exciting strides in pet diabetes treatment
Ink KC – March 18, 2015